{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:41:26Z","timestamp":1792813286679,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T00:00:00Z","timestamp":1673049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T00:00:00Z","timestamp":1673049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Japan Society for the Promotion of Science (JAPS) KAKENHI","award":["18K08413"],"award-info":[{"award-number":["18K08413"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-023-00988-4","type":"journal-article","created":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T17:06:21Z","timestamp":1673111181000},"page":"3407-3416","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Differences and similarities in cytokine profiles of macrophage activation syndrome in systemic lupus erythematosus and adult-onset Still\u2019s disease"],"prefix":"10.1007","volume":"23","author":[{"given":"Tomoka","family":"Hiyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Kurasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Miyao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayae","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Arima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reika","family":"Maezawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,7]]},"reference":[{"key":"988_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-pathol-020117-043625","volume":"13","author":"H Al-Samkari","year":"2018","unstructured":"Al-Samkari H, Berliner N. Hemophagocytic lymphohistiocytosis. Annu Rev Pathol. 2018;13:27\u201349. https:\/\/doi.org\/10.1146\/annurev-pathol-020117-043625.","journal-title":"Annu Rev Pathol"},{"key":"988_CR2","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1182\/blood.2018894618","volume":"133","author":"P La Ros\u00e9e","year":"2019","unstructured":"La Ros\u00e9e P, Horne A, Hines M, von Bahr Greenwood T, Machowicz R, Berliner N, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019;133:2465\u201377. https:\/\/doi.org\/10.1182\/blood.2018894618.","journal-title":"Blood"},{"key":"988_CR3","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMra2026131","volume":"383","author":"DC Fajgenbaum","year":"2020","unstructured":"Fajgenbaum DC, June CH. Cytokine Storm. N Engl J Med. 2020;383:2255\u201373. https:\/\/doi.org\/10.1056\/NEJMra2026131.","journal-title":"N Engl J Med"},{"key":"988_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrrheum.2015.171","volume":"12","author":"AA Grom","year":"2016","unstructured":"Grom AA, Horne A, DeBenedetti F. Macrophage activation syndrome in the era of biologic therapy. Nat Rev Rheumatol. 2016;12:259\u201368. https:\/\/doi.org\/10.1038\/nrrheum.2015.171.","journal-title":"Nat Rev Rheumatol"},{"key":"988_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/rheumatology\/key006","volume":"58","author":"SJ Carter","year":"2019","unstructured":"Carter SJ, Tattersall RS, Ramanan AV. Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment. Rheumatology (Oxford). 2019;58:5\u201317. https:\/\/doi.org\/10.1093\/rheumatology\/key006.","journal-title":"Rheumatology (Oxford)"},{"key":"988_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fimmu.2019.00119","volume":"10","author":"CB Crayne","year":"2019","unstructured":"Crayne CB, Albeituni S, Nichols KE, Cron RQ. The Immunology of macrophage activation syndrome. Front Immunol. 2019;10:119. https:\/\/doi.org\/10.3389\/fimmu.2019.00119.","journal-title":"Front Immunol"},{"key":"988_CR7","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1002\/art.38802","volume":"66","author":"F Minoia","year":"2014","unstructured":"Minoia F, Dav\u00ec S, Horne A, Demirkaya E, Bovis F, Li C, et al. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. Arthritis Rheumatol. 2014;66:3160\u20139. https:\/\/doi.org\/10.1002\/art.38802.","journal-title":"Arthritis Rheumatol"},{"key":"988_CR8","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3899\/jrheum.170955","volume":"45","author":"P Ruscitti","year":"2018","unstructured":"Ruscitti P, Iacono D, Ciccia F, Emmi G, Cipriani P, Grembiale RD, et al. Macrophage activation syndrome in patients affected by adult-onset still disease: analysis of survival rates and predictive factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale Cohort. J Rheumatol. 2018;45:864\u201372. https:\/\/doi.org\/10.3899\/jrheum.170955.","journal-title":"J Rheumatol"},{"key":"988_CR9","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/art.40417","volume":"70","author":"RE Borgia","year":"2018","unstructured":"Borgia RE, Gerstein M, Levy DM, Silverman ED, Hiraki LT. Features, treatment, and outcomes of macrophage activation syndrome in childhood-onset systemic lupus erythematosus. Arthritis Rheumatol. 2018;70:616\u201324. https:\/\/doi.org\/10.1002\/art.40417.","journal-title":"Arthritis Rheumatol"},{"key":"988_CR10","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.autrev.2017.05.010","volume":"16","author":"PE Gavand","year":"2017","unstructured":"Gavand PE, Serio I, Arnaud L, Costedoat-Chalumeau N, Carvelli J, Dossier A, et al. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 103 episodes in 89 adult patients. Autoimmun Rev. 2017;16:743\u20139. https:\/\/doi.org\/10.1016\/j.autrev.2017.05.010.","journal-title":"Autoimmun Rev"},{"key":"988_CR11","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41584-018-0081-x","volume":"14","author":"E Feist","year":"2018","unstructured":"Feist E, Mitrovic S, Fautrel B. Mechanisms, biomarkers and targets for adult-onset Still\u2019s disease. Nat Rev Rheumatol. 2018;14:603\u201318. https:\/\/doi.org\/10.1038\/s41584-018-0081-x.","journal-title":"Nat Rev Rheumatol"},{"key":"988_CR12","first-page":"137","volume-title":"Dubois' lupus erythematosus and related syndromes","author":"MK Crow","year":"2018","unstructured":"Crow MK, Kirou KA, Niewold TB. Cytokines in lupus. In: Wallace D, Hahn B, editors. Dubois\u2019 lupus erythematosus and related syndromes. 9th ed. Elsevier; 2018. p. 137\u201352.","edition":"9"},{"key":"988_CR13","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. For the diagnostic and therapeutic criteria committee of the american college of rheumatology. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725. https:\/\/doi.org\/10.1002\/art.1780400928.","journal-title":"Arthritis Rheum"},{"key":"988_CR14","first-page":"424","volume":"19","author":"M Yamaguchi","year":"1992","unstructured":"Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima H, Kashiwagi H, et al. Preliminary criteria for classification of adult Still\u2019s disease. J Rheumatol. 1992;19:424\u201330.","journal-title":"J Rheumatol"},{"key":"988_CR15","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/ajcp\/aqw076","volume":"145","author":"F Debaugnies","year":"2016","unstructured":"Debaugnies F, Mahadeb B, Ferster A, Meuleman N, Rozen L, Demulder A, et al. Performances of the H-score for diagnosis of hemophagocytic lymphohistiocytosis in adult and pediatric patients. Am J Clin Pathol. 2016;145:862\u201370. https:\/\/doi.org\/10.1093\/ajcp\/aqw076.","journal-title":"Am J Clin Pathol"},{"key":"988_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124\u201331. https:\/\/doi.org\/10.1002\/pbc.21039.","journal-title":"Pediatr Blood Cancer"},{"key":"988_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.coi.2020.10.014","volume":"67","author":"M Postal","year":"2020","unstructured":"Postal M, Vivaldo JF, Fernandez-Ruiz R, Paredes JL, Appenzeller S, Niewold TB. Type I interferon in the pathogenesis of systemic lupus erythematosus. Curr Opin Immunol. 2020;67:87\u201394. https:\/\/doi.org\/10.1016\/j.coi.2020.10.014.","journal-title":"Curr Opin Immunol"},{"key":"988_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa1912196","volume":"382","author":"EF Morand","year":"2020","unstructured":"Morand EF, Furie R, Tanaka Y, Bruce IN, Askanase AD, Richez C, et al. Trial of anifrolumab in active systemic lupus erythematosus. N Engl J Med. 2020;382:211\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1912196.","journal-title":"N Engl J Med"},{"key":"988_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/roac010","author":"Y Tanaka","year":"2022","unstructured":"Tanaka Y, Atsumi T, Okada M, Miyamura T, Ishii T, Nishiyama S, et al. The efficacy and safety of anifrolumab in Japanese patients with systemic lupus erythematosus: TULIP-2 subanalysis. Mod Rheumatol. 2022. https:\/\/doi.org\/10.1093\/mr\/roac010.","journal-title":"Mod Rheumatol"},{"key":"988_CR20","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1089\/107999099313901","volume":"19","author":"WJ Jabs","year":"1999","unstructured":"Jabs WJ, Hennig C, Zawatzky R, Kirchner H. Failure to detect antiviral activity in serum and plasma of healthy individuals displaying high activity in ELISA for IFN-alpha and IFN-beta. J Interferon Cytokine Res. 1999;19:463\u20139. https:\/\/doi.org\/10.1089\/107999099313901.","journal-title":"J Interferon Cytokine Res"},{"key":"988_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2019.108255.10.1016\/j.clim.2019.108255","author":"M Usami","year":"2019","unstructured":"Usami M, Shimizu M, Mizuta M, Inoue N, Irabu H, Sakumura N, et al. Extensive serum biomarker analysis in patients with macrophage activation syndrome associated with systemic lupus erythematosus. Clin Immunol. 2019. https:\/\/doi.org\/10.1016\/j.clim.2019.108255.10.1016\/j.clim.2019.108255.","journal-title":"Clin Immunol"},{"key":"988_CR22","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/rheumatology\/keaa299","volume":"60","author":"M Mizuta","year":"2021","unstructured":"Mizuta M, Shimizu M, Irabu H, Usami M, Inoue N, Nakagishi Y, et al. Comparison of serum cytokine profiles in macrophage activation syndrome complicating different background rheumatic diseases in children. Rheumatology (Oxford). 2021;60:231\u20138. https:\/\/doi.org\/10.1093\/rheumatology\/keaa299.","journal-title":"Rheumatology (Oxford)"},{"key":"988_CR23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13075-019-1878-y","volume":"21","author":"V Oke","year":"2019","unstructured":"Oke V, Gunnarsson I, Dorschner J, Eketj\u00e4ll S, Zickert A, Niewold TB, et al. High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus. Arthritis Res Ther. 2019;21:107. https:\/\/doi.org\/10.1186\/s13075-019-1878-y.","journal-title":"Arthritis Res Ther"},{"key":"988_CR24","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.berh.2018.02.002","volume":"31","author":"M Pardeo","year":"2017","unstructured":"Pardeo M, Bracaglia C, De Benedetti F. Systemic juvenile idiopathic arthritis: new insights into pathogenesis and cytokine directed therapies. Best Pract Res Clin Rheumatol. 2017;31:505\u201316. https:\/\/doi.org\/10.1016\/j.berh.2018.02.002.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"988_CR25","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1093\/rheumatology\/keu524","volume":"54","author":"K Put","year":"2015","unstructured":"Put K, Avau A, Brisse E, Mitera T, Put S, Proost P, et al. Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-\u03b3. Rheumatology (Oxford). 2015;54:1507\u201317. https:\/\/doi.org\/10.1093\/rheumatology\/keu524.","journal-title":"Rheumatology (Oxford)"},{"key":"988_CR26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.clim.2016.05.010","volume":"169","author":"N Inoue","year":"2016","unstructured":"Inoue N, Shimizu M, Tsunoda S, Kawano M, Matsumura M, Yachie A. Cytokine profile in adult-onset Still\u2019s disease: comparison with systemic juvenile idiopathic arthritis. Clin Immunol. 2016;169:8\u201313. https:\/\/doi.org\/10.1016\/j.clim.2016.05.010.","journal-title":"Clin Immunol"},{"key":"988_CR27","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.semarthrit.2021.06.004","volume":"51","author":"P Efthimiou","year":"2021","unstructured":"Efthimiou P, Kontzias A, Hur P, Rodha K, Ramakrishna GS, Nakasato P. Adult-onset Still\u2019s disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies. Semin Arthritis Rheum. 2021;51:858\u201374. https:\/\/doi.org\/10.1016\/j.semarthrit.2021.06.004.","journal-title":"Semin Arthritis Rheum"},{"key":"988_CR28","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1093\/rheumatology\/keq133","volume":"49","author":"M Shimizu","year":"2010","unstructured":"Shimizu M, Yokoyama T, Yamada K, Kaneda H, Wada H, Wada T, et al. Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis. Rheumatology (Oxford). 2010;49:1645\u201353. https:\/\/doi.org\/10.1093\/rheumatology\/keq133.","journal-title":"Rheumatology (Oxford)"},{"key":"988_CR29","doi-asserted-by":"publisher","first-page":"750114","DOI":"10.3389\/fimmu.2021.750114","volume":"12","author":"T Shiga","year":"2021","unstructured":"Shiga T, Nozaki Y, Tomita D, Kishimoto K, Hirooka Y, Kinoshita K, et al. Usefulness of Interleukin-18 as a diagnostic biomarker to differentiate adult-onset Still\u2019s disease with\/without macrophage activation syndrome from other secondary hemophagocytic lymphohistiocytosis in adults. Front Immunol. 2021;12:750114. https:\/\/doi.org\/10.3389\/fimmu.2021.750114.","journal-title":"Front Immunol"},{"key":"988_CR30","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/rheumatology\/kez284","volume":"59","author":"S Yasin","year":"2020","unstructured":"Yasin S, Solomon K, Canna SW, Girard-Guyonvarc\u2019h C, Gabay C, Schiffrin E, et al. IL-18 as therapeutic target in a patient with resistant systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome. Rheumatology (Oxford). 2020;59:442\u20135. https:\/\/doi.org\/10.1093\/rheumatology\/kez284.","journal-title":"Rheumatology (Oxford)"},{"key":"988_CR31","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/acr.23277","volume":"70","author":"GS Schulert","year":"2018","unstructured":"Schulert GS, Minoia F, Bohnsack J, Cron RQ, Hashad S, Kon\u00c9-Paut I, et al. Effect of biologic therapy on clinical and laboratory features of macrophage activation syndrome associated with systemic juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2018;70:409\u201319. https:\/\/doi.org\/10.1002\/acr.23277.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"988_CR32","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1136\/annrheumdis-2015-209020","volume":"76","author":"C Bracaglia","year":"2017","unstructured":"Bracaglia C, de Graaf K, Pires Marafon D, Guilhot F, Ferlin W, Prencipe G, et al. Elevated circulating levels of interferon-\u03b3 and interferon-\u03b3-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Ann Rheum Dis. 2017;76:166\u201372. https:\/\/doi.org\/10.1136\/annrheumdis-2015-209020.","journal-title":"Ann Rheum Dis"},{"key":"988_CR33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/rheumatology\/keac247","volume":"62","author":"P Ruscitti","year":"2022","unstructured":"Ruscitti P, Ursini F, Berardicurti O, Masedu F, Bozzalla Cassione E, et al. Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still\u2019s disease. Rheumatology (Oxford). 2022;62:321\u20139. https:\/\/doi.org\/10.1093\/rheumatology\/keac247.","journal-title":"Rheumatology (Oxford)"},{"key":"988_CR34","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/rheumatology\/keab673","volume":"61","author":"EL Verweyen","year":"2022","unstructured":"Verweyen EL, Schulert GS. Interfering with interferons: targeting the JAK-STAT pathway in complications of systemic juvenile idiopathic arthritis (SJIA). Rheumatology (Oxford). 2022;61:926\u201335. https:\/\/doi.org\/10.1093\/rheumatology\/keab673.","journal-title":"Rheumatology (Oxford)"},{"key":"988_CR35","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1182\/blood-2021-147596","volume":"138","author":"F De Benedetti","year":"2021","unstructured":"De Benedetti F, Grom AA, Brogan P, Bracaglia C, Pardeo M, Marucci G, Eleftheriou D, Papadopoulou C, Quartier P. Macrophage activation syndrome (MAS) in systemic juvenile idiopathic arthritis (sJIA): treatment with emapalumab, an anti-interferon gamma (IFN\u03b3) monoclonal antibody. Blood. 2021;138:2058. https:\/\/doi.org\/10.1182\/blood-2021-147596.","journal-title":"Blood"},{"key":"988_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13075-021-02708-3","volume":"24","author":"T Sugiyama","year":"2022","unstructured":"Sugiyama T, Furuta S, Hiraguri M, Ikeda K, Inaba Y, Kagami SI, et al. Latent class analysis of 216 patients with adult-onset Still\u2019s disease. Arthritis Res Ther. 2022;24:7. https:\/\/doi.org\/10.1186\/s13075-021-02708-3.","journal-title":"Arthritis Res Ther"},{"key":"988_CR37","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3899\/jrheum.090662","volume":"37","author":"J Maruyama","year":"2010","unstructured":"Maruyama J, Inokuma S. Cytokine profiles of macrophage activation syndrome associated with rheumatic diseases. J Rheumatol. 2010;37:967\u201373. https:\/\/doi.org\/10.3899\/jrheum.090662.","journal-title":"J Rheumatol"},{"key":"988_CR38","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1189\/jlb.72.6.1148","volume":"72","author":"B Wirleitner","year":"2002","unstructured":"Wirleitner B, Reider D, Ebner S, Bock G, Widner B, Jaeger M, et al. Monocyte-derived dendritic cells release neopterin. J Leukoc Biol. 2002;72:1148\u201353. https:\/\/doi.org\/10.1189\/jlb.72.6.1148.","journal-title":"J Leukoc Biol"},{"key":"988_CR39","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1002\/art.38769","volume":"66","author":"S Dav\u00ec","year":"2014","unstructured":"Dav\u00ec S, Minoia F, Pistorio A, Horne A, Consolaro A, Rosina S, et al. Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Arthritis Rheumatol. 2014;66:2871\u201380. https:\/\/doi.org\/10.1002\/art.38769.","journal-title":"Arthritis Rheumatol"},{"key":"988_CR40","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1002\/art.24883","volume":"60","author":"A Parodi","year":"2009","unstructured":"Parodi A, Dav\u00ec S, Pringe AB, Pistorio A, Ruperto N, Magni-Manzoni S, et al. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. Arthritis Rheum. 2009;60:3388\u201399. https:\/\/doi.org\/10.1002\/art.24883.","journal-title":"Arthritis Rheum"},{"key":"988_CR41","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/annrheumdis-2015-208982","volume":"75","author":"A Ravelli","year":"2016","unstructured":"Ravelli A, Minoia F, Dav\u00ec S, Horne A, Bovis F, et al. Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European league against rheumatism\/American college of rheumatology\/paediatric rheumatology international trials organisation collaborative initiative. Ann Rheum Dis. 2016;75:481\u20139. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208982.","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-00988-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-023-00988-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-00988-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T20:07:01Z","timestamp":1698782821000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-023-00988-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,7]]},"references-count":41,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["988"],"URL":"https:\/\/doi.org\/10.1007\/s10238-023-00988-4","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,7]]},"assertion":[{"value":"12 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"KK has received research support from Asahi-Kasei, Boehringer-Ingelheim, Chugai, Eisai, Japan Blood Products Organization, and Ono outside the submitted work. The other authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted per the Declaration of Helsinki and according to Ethical Guidelines for clinical studies 2011 by the Ministry of Education, Culture, Sports, Science and Technology and Ministry of Health, Labor and Welfare, Japan. This study was approved by the local Ethics Committee Bioethics Committee Dokkyo Medical University (#22081).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This study was conducted and written informed consent was obtained from each patient for the use of serum samples and clinical and laboratory data when the sample was obtained.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}